Document_and_Entity_Informatio
Document and Entity Information | 9 Months Ended | |
Nov. 02, 2013 | Nov. 30, 2013 | |
Document and Entity Information [Abstract] | ' | ' |
Entity Registrant Name | 'KOHLS CORP | ' |
Entity Central Index Key | '0000885639 | ' |
Current Fiscal Year End Date | '--02-01 | ' |
Entity Filer Category | 'Large Accelerated Filer | ' |
Trading Symbol | 'KSS | ' |
Document Type | '10-Q | ' |
Document Period End Date | 2-Nov-13 | ' |
Document Fiscal Year Focus | '2013 | ' |
Document Fiscal Period Focus | 'Q3 | ' |
Amendment Flag | 'false | ' |
Entity Common Stock, Shares Outstanding | ' | 214,139,923 |
CONSOLIDATED_BALANCE_SHEETS
CONSOLIDATED BALANCE SHEETS (USD $) | Nov. 02, 2013 | Feb. 02, 2013 | Oct. 27, 2012 |
In Millions, unless otherwise specified | |||
Current assets: | ' | ' | ' |
Cash and cash equivalents | $598 | $537 | $550 |
Merchandise inventories | 4,959 | 3,748 | 4,851 |
Deferred income taxes | 147 | 122 | 124 |
Other | 283 | 312 | 281 |
Total current assets | 5,987 | 4,719 | 5,806 |
Property and equipment, net | 8,925 | 8,872 | 9,009 |
Long-term investments | 57 | 53 | 90 |
Other assets | 276 | 261 | 256 |
Total assets | 15,245 | 13,905 | 15,161 |
Current liabilities: | ' | ' | ' |
Accounts payable | 2,261 | 1,307 | 2,429 |
Accrued liabilities | 1,198 | 986 | 1,127 |
Income taxes payable | 41 | 137 | 48 |
Current portion of capital lease and financing obligations | 141 | 105 | 100 |
Total current liabilities | 3,641 | 2,535 | 3,704 |
Long-term debt | 2,792 | 2,492 | 2,492 |
Capital lease and financing obligations | 1,950 | 1,956 | 1,986 |
Deferred income taxes | 390 | 362 | 395 |
Other long-term liabilities | 548 | 512 | 478 |
Shareholders’ equity: | ' | ' | ' |
Common stock | 4 | 4 | 4 |
Paid-in capital | 2,557 | 2,454 | 2,423 |
Treasury stock, at cost | -7,802 | -7,243 | -6,848 |
Accumulated other comprehensive loss | -39 | -45 | -48 |
Retained earnings | 11,204 | 10,878 | 10,575 |
Total shareholders’ equity | 5,924 | 6,048 | 6,106 |
Total liabilities and shareholders’ equity | $15,245 | $13,905 | $15,161 |
CONSOLIDATED_STATEMENTS_OF_INC
CONSOLIDATED STATEMENTS OF INCOME (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, except Per Share data, unless otherwise specified | Nov. 02, 2013 | Oct. 27, 2012 | Nov. 02, 2013 | Oct. 27, 2012 |
Net sales | $4,444 | $4,490 | $12,932 | $12,937 |
Cost of merchandise sold (exclusive of depreciation shown separately below) | 2,778 | 2,778 | 8,063 | 8,059 |
Gross margin | 1,666 | 1,712 | 4,869 | 4,878 |
Operating expenses: | ' | ' | ' | ' |
Selling, general, and administrative | 1,073 | 1,077 | 3,071 | 3,055 |
Depreciation and amortization | 228 | 210 | 665 | 620 |
Operating income | 365 | 425 | 1,133 | 1,203 |
Interest expense, net | 84 | 80 | 251 | 243 |
Income before income taxes | 281 | 345 | 882 | 960 |
Provision for income taxes | 104 | 130 | 327 | 351 |
Net income | $177 | $215 | $555 | $609 |
Net income per share: | ' | ' | ' | ' |
Basic (in dollars per share) | $0.82 | $0.92 | $2.53 | $2.56 |
Diluted (in dollars per share) | $0.81 | $0.91 | $2.51 | $2.54 |
Dividends declared and paid per share | $0.35 | $0.32 | $1.05 | $0.96 |
CONSOLIDATED_STATEMENTS_OF_COM
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, unless otherwise specified | Nov. 02, 2013 | Oct. 27, 2012 | Nov. 02, 2013 | Oct. 27, 2012 |
Statement of Other Comprehensive Income [Abstract] | ' | ' | ' | ' |
Net income | $177 | $215 | $555 | $609 |
Other comprehensive income, net of tax: | ' | ' | ' | ' |
Unrealized gains on investments | 0 | 3 | 4 | 3 |
Reclassification adjustment for interest expense on interest rate derivative included in net income | 1 | 1 | 2 | 2 |
Other comprehensive income | 1 | 4 | 6 | 5 |
Comprehensive income | $178 | $219 | $561 | $614 |
CONSOLIDATED_STATEMENT_OF_CHAN
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (USD $) | Total | Common Stock | Paid-In Capital | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Retained Earnings [Member] |
In Millions | ||||||
Beginning Balance at Feb. 02, 2013 | $6,048 | $4 | $2,454 | ($7,243) | ($45) | $10,878 |
Beginning Balance (in shares) at Feb. 02, 2013 | ' | 360 | ' | -138 | ' | ' |
Comprehensive income (loss) | 561 | ' | ' | ' | 6 | 555 |
Stock options and awards, (in shares) | ' | 3 | ' | ' | ' | ' |
Stock options and awards | 120 | ' | 120 | ' | ' | ' |
Net income tax impact from exercise of stock options | -17 | ' | -17 | ' | ' | ' |
Dividends paid ($1.05 per common share) | -226 | ' | 0 | 3 | ' | -229 |
Treasury stock purchases, (in shares) | ' | ' | ' | -11 | ' | ' |
Treasury stock purchases | -562 | ' | ' | -562 | ' | ' |
Ending Balance at Nov. 02, 2013 | $5,924 | $4 | $2,557 | ($7,802) | ($39) | $11,204 |
Ending Balance (in shares) at Nov. 02, 2013 | ' | 363 | ' | -149 | ' | ' |
CONSOLIDATED_STATEMENT_OF_CHAN1
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) (USD $) | 3 Months Ended | 9 Months Ended | ||
Nov. 02, 2013 | Oct. 27, 2012 | Nov. 02, 2013 | Oct. 27, 2012 | |
Statement of Stockholders' Equity [Abstract] | ' | ' | ' | ' |
Dividends declared and paid per share | $0.35 | $0.32 | $1.05 | $0.96 |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 9 Months Ended | |
In Millions, unless otherwise specified | Nov. 02, 2013 | Oct. 27, 2012 |
Operating activities | ' | ' |
Net income | $555 | $609 |
Adjustments to reconcile net income to net cash provided by operating activities: | ' | ' |
Depreciation and amortization | 665 | 620 |
Share-based compensation | 41 | 37 |
Excess tax benefits from share-based compensation | -3 | -3 |
Deferred income taxes | -1 | -46 |
Other non-cash revenues and expenses | 30 | 26 |
Changes in operating assets and liabilities: | ' | ' |
Merchandise inventories | -1,204 | -1,628 |
Other current and long-term assets | 11 | 30 |
Accounts payable | 954 | 1,196 |
Accrued and other long-term liabilities | 79 | -47 |
Income taxes | -113 | -91 |
Net cash provided by operating activities | 1,014 | 703 |
Investing activities | ' | ' |
Acquisition of property and equipment | -465 | -641 |
Sales of investments in auction rate securities | 1 | 68 |
Other | 13 | 5 |
Net cash used in investing activities | -451 | -568 |
Financing activities | ' | ' |
Treasury stock purchases | -562 | -883 |
Dividends paid | -229 | -227 |
Proceeds from Issuance of Debt | 300 | 350 |
Proceeds from financing obligations | 0 | 7 |
Capital lease and financing obligation payments | -87 | -87 |
Proceeds from stock option exercises | 77 | 50 |
Excess tax benefits from share-based compensation | 3 | 3 |
Payments of Financing Costs | 4 | 3 |
Net cash used in financing activities | -502 | -790 |
Net increase (decrease) in cash and cash equivalents | 61 | -655 |
Cash and cash equivalents at beginning of period | 537 | 1,205 |
Cash and cash equivalents at end of period | 598 | 550 |
Supplemental information: | ' | ' |
Interest paid, net of capitalized interest | 221 | 207 |
Income taxes paid | 438 | 490 |
Non-Cash Investing and Financing Activities | ' | ' |
Property and equipment acquired through additional liabilities | $119 | $60 |
Basis_of_Presentation
Basis of Presentation | 9 Months Ended |
Nov. 02, 2013 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Business and Summary of Accounting Policies | ' |
Basis of Presentation | |
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for fiscal year end financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. For further information, refer to the financial statements and related footnotes included in our Annual Report on Form 10-K for the fiscal year ended February 2, 2013 (Commission File No. 1-11084) as filed with the Securities and Exchange Commission on March 22, 2013. | |
Due to the seasonality of our business, results for any quarter are not necessarily indicative of the results that may be achieved for a full fiscal year. In addition, quarterly results of operations may be impacted by the timing and amount of sales and costs associated with the opening of new stores. | |
We operate as a single business unit. | |
To conform to the current year presentations, we have corrected the presentation of $33 million of deferred revenues that were previously recorded as a reduction to merchandise inventory as of October 27, 2012. |
Debt
Debt | 9 Months Ended | |||||||||||||
Nov. 02, 2013 | ||||||||||||||
Debt [Abstract] | ' | |||||||||||||
Debt | ' | |||||||||||||
Debt | ||||||||||||||
Long-term debt consists of the following unsecured senior debt: | ||||||||||||||
Outstanding | ||||||||||||||
Maturity | Effective | Coupon Rate | November 2, 2013 | February 2, 2013 and October 27, 2012 | ||||||||||
Rate | ||||||||||||||
(Dollars in Millions) | ||||||||||||||
2017 | 6.31 | % | 6.25 | % | $ | 650 | $ | 650 | ||||||
2021 | 4.81 | % | 4 | % | 650 | 650 | ||||||||
2023 | 3.25 | % | 3.25 | % | 350 | 350 | ||||||||
2023 | 4.78 | % | 4.75 | % | 300 | — | ||||||||
2029 | 7.36 | % | 7.25 | % | 200 | 200 | ||||||||
2033 | 6.05 | % | 6 | % | 300 | 300 | ||||||||
2037 | 6.89 | % | 6 | % | 350 | 350 | ||||||||
5.54 | % | 2,800 | 2,500 | |||||||||||
Unamortized debt discount | (8 | ) | (8 | ) | ||||||||||
Long-term debt | $ | 2,792 | $ | 2,492 | ||||||||||
In September 2013, we issued $300 million of4.75% notes with semi-annual interest payments beginning December 2013. The notes mature on December 2023. |
Fair_Value_Measurements
Fair Value Measurements | 9 Months Ended | |||||||||||||||||||||||||
Nov. 02, 2013 | ||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||||||||||||||
Fair Value Measurements | ' | |||||||||||||||||||||||||
Fair Value Measurements | ||||||||||||||||||||||||||
ASC No. 820, “Fair Value Measurements and Disclosures,” requires fair value measurements be classified and disclosed in one of the following pricing categories: | ||||||||||||||||||||||||||
Level 1: | Financial instruments with unadjusted, quoted prices listed on active market exchanges. | |||||||||||||||||||||||||
Level 2: | Financial instruments lacking unadjusted, quoted prices from active market exchanges, including over-the-counter traded financial instruments. The prices for the financial instruments are determined using prices for recently traded financial instruments with similar underlying terms as well as directly or indirectly observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. | |||||||||||||||||||||||||
Level 3: | Financial instruments that are not actively traded on a market exchange. This category includes situations where there is little, if any, market activity for the financial instrument. The prices are determined using significant unobservable inputs or valuation techniques. | |||||||||||||||||||||||||
The following table summarizes our financial instruments: | ||||||||||||||||||||||||||
November 2, 2013 | February 2, 2013 | October 27, 2012 | ||||||||||||||||||||||||
Pricing Category | Cost | Fair Value | Cost | Fair Value | Cost | Fair Value | ||||||||||||||||||||
(In Millions) | ||||||||||||||||||||||||||
Cash and cash equivalents | Level 1 | $ | 598 | $ | 598 | $ | 537 | $ | 537 | $ | 550 | $ | 550 | |||||||||||||
Long-term investments | Level 3 | 82 | 57 | 84 | 53 | 124 | 90 | |||||||||||||||||||
Debt | Level 1 | 2,792 | 2,960 | 2,492 | 2,702 | 2,492 | 2,894 | |||||||||||||||||||
Our long-term investments consist primarily of investments in auction rate securities (“ARS”). The fair values for our ARS were based on third-party pricing models which utilized a discounted cash flow model for each of the securities as there was no recent activity in the secondary markets in these types of securities. This model used a combination of observable inputs which were developed using publicly available market data obtained from independent sources and unobservable inputs that reflect our own estimates of the assumptions that market participants would use in pricing the investments. Observable inputs include interest rate currently being paid, maturity and credit ratings. | ||||||||||||||||||||||||||
Unobservable inputs include expected redemption date and discount rate. We assumed a seven-year redemption period in valuing our ARS. We intend to hold our ARS until maturity or until we can liquidate them at par value. Based on our other sources of income, we do not believe we will be required to sell them before recovery of par value. In some cases, holding the security until recovery may mean until maturity, which ranges from 2037 to 2039. The discount rate was calculated using the closest match available for other insured asset backed securities. Discount rates ranged from 6.57% to 9.47%. The weighted-average discount rate was 7.64%. A market failure scenario was employed as recent successful auctions of these securities were very limited. Assuming a longer redemption period and a higher discount rate would result in a lower fair market value. Similarly, assuming a shorter redemption period and a lower discount rate would result in a higher fair market value. | ||||||||||||||||||||||||||
The following table presents a rollforward of our long-term investments: | ||||||||||||||||||||||||||
Nine Months Ended | ||||||||||||||||||||||||||
November 2, | October 27, | |||||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||||
(In Millions) | ||||||||||||||||||||||||||
Balance at beginning of year | $ | 53 | $ | 153 | ||||||||||||||||||||||
Sales | (2 | ) | (68 | ) | ||||||||||||||||||||||
Unrealized gains | 6 | 5 | ||||||||||||||||||||||||
Balance at end of period | $ | 57 | $ | 90 | ||||||||||||||||||||||
StockBased_Compensation
Stock-Based Compensation | 9 Months Ended | |||||||||||||||
Nov. 02, 2013 | ||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | ' | |||||||||||||||
Stock-Based Compensation | ||||||||||||||||
The following table summarizes our stock-based compensation expense: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
2-Nov-13 | 27-Oct-12 | 2-Nov-13 | 27-Oct-12 | |||||||||||||
(In Millions) | ||||||||||||||||
Stock options | $ | 4 | $ | 5 | $ | 13 | $ | 22 | ||||||||
Restricted shares | 10 | 8 | 28 | 15 | ||||||||||||
Total stock-based compensation expense | $ | 14 | $ | 13 | $ | 41 | $ | 37 | ||||||||
The following table summarizes stock-based compensation grants: | ||||||||||||||||
Nine Months Ended | ||||||||||||||||
2-Nov-13 | 27-Oct-12 | |||||||||||||||
(In Thousands) | ||||||||||||||||
Stock options granted | 549 | 1,387 | ||||||||||||||
Restricted shares granted, excluding shares earned in lieu of cash dividends | 873 | 1,001 | ||||||||||||||
Total stock-based compensation grants | 1,422 | 2,388 | ||||||||||||||
Weighted average fair value at grant date: | ||||||||||||||||
Stock options | $ | 10.57 | $ | 11.84 | ||||||||||||
Restricted shares | $ | 47.97 | $ | 49 | ||||||||||||
Contingencies
Contingencies | 9 Months Ended |
Nov. 02, 2013 | |
Commitments and Contingencies Disclosure [Abstract] | ' |
Contingencies | ' |
Contingencies | |
We are subject to certain legal proceedings and claims arising out of the conduct of our business. In the opinion of management, the outcome of these proceedings and litigation will not have a material adverse impact on our consolidated financial statements. |
Net_Income_Per_Section
Net Income Per Section | 9 Months Ended | |||||||||||||||
Nov. 02, 2013 | ||||||||||||||||
Net Income Per Section [Abstract] | ' | |||||||||||||||
Earnings Per Share | ' | |||||||||||||||
Net Income Per Share | ||||||||||||||||
The following table summarizes our basic and diluted net income per share calculations: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
November 2, | October 27, | November 2, | October 27, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
(In Millions) | ||||||||||||||||
Numerator—Net income | $ | 177 | $ | 215 | $ | 555 | $ | 609 | ||||||||
Denominator—Weighted average shares: | ||||||||||||||||
Basic | 216 | 233 | 219 | 238 | ||||||||||||
Impact of dilutive employee stock options | 2 | 2 | 2 | 2 | ||||||||||||
Diluted | 218 | 235 | 221 | 240 | ||||||||||||
Antidilutive shares | 8 | 9 | 12 | 13 | ||||||||||||
Debt_Tables
Debt (Tables) | 9 Months Ended | |||||||||||||
Nov. 02, 2013 | ||||||||||||||
Debt Disclosure [Abstract] | ' | |||||||||||||
Components of long-term debt | ' | |||||||||||||
Long-term debt consists of the following unsecured senior debt: | ||||||||||||||
Outstanding | ||||||||||||||
Maturity | Effective | Coupon Rate | November 2, 2013 | February 2, 2013 and October 27, 2012 | ||||||||||
Rate | ||||||||||||||
(Dollars in Millions) | ||||||||||||||
2017 | 6.31 | % | 6.25 | % | $ | 650 | $ | 650 | ||||||
2021 | 4.81 | % | 4 | % | 650 | 650 | ||||||||
2023 | 3.25 | % | 3.25 | % | 350 | 350 | ||||||||
2023 | 4.78 | % | 4.75 | % | 300 | — | ||||||||
2029 | 7.36 | % | 7.25 | % | 200 | 200 | ||||||||
2033 | 6.05 | % | 6 | % | 300 | 300 | ||||||||
2037 | 6.89 | % | 6 | % | 350 | 350 | ||||||||
5.54 | % | 2,800 | 2,500 | |||||||||||
Unamortized debt discount | (8 | ) | (8 | ) | ||||||||||
Long-term debt | $ | 2,792 | $ | 2,492 | ||||||||||
Fair_Value_Measurements_Tables
Fair Value Measurements (Tables) | 9 Months Ended | |||||||||||||||||||||||||
Nov. 02, 2013 | ||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||||||||||||||
Summary of Financial Instruments | ' | |||||||||||||||||||||||||
The following table summarizes our financial instruments: | ||||||||||||||||||||||||||
November 2, 2013 | February 2, 2013 | October 27, 2012 | ||||||||||||||||||||||||
Pricing Category | Cost | Fair Value | Cost | Fair Value | Cost | Fair Value | ||||||||||||||||||||
(In Millions) | ||||||||||||||||||||||||||
Cash and cash equivalents | Level 1 | $ | 598 | $ | 598 | $ | 537 | $ | 537 | $ | 550 | $ | 550 | |||||||||||||
Long-term investments | Level 3 | 82 | 57 | 84 | 53 | 124 | 90 | |||||||||||||||||||
Debt | Level 1 | 2,792 | 2,960 | 2,492 | 2,702 | 2,492 | 2,894 | |||||||||||||||||||
Long-Term Investments | ' | |||||||||||||||||||||||||
The following table presents a rollforward of our long-term investments: | ||||||||||||||||||||||||||
Nine Months Ended | ||||||||||||||||||||||||||
November 2, | October 27, | |||||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||||
(In Millions) | ||||||||||||||||||||||||||
Balance at beginning of year | $ | 53 | $ | 153 | ||||||||||||||||||||||
Sales | (2 | ) | (68 | ) | ||||||||||||||||||||||
Unrealized gains | 6 | 5 | ||||||||||||||||||||||||
Balance at end of period | $ | 57 | $ | 90 | ||||||||||||||||||||||
StockBased_Compensation_Tables
Stock-Based Compensation (Tables) | 9 Months Ended | |||||||||||||||
Nov. 02, 2013 | ||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||||||||
Summary of stock option activity | ' | |||||||||||||||
The following table summarizes our stock-based compensation expense: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
2-Nov-13 | 27-Oct-12 | 2-Nov-13 | 27-Oct-12 | |||||||||||||
(In Millions) | ||||||||||||||||
Stock options | $ | 4 | $ | 5 | $ | 13 | $ | 22 | ||||||||
Restricted shares | 10 | 8 | 28 | 15 | ||||||||||||
Total stock-based compensation expense | $ | 14 | $ | 13 | $ | 41 | $ | 37 | ||||||||
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] | ' | |||||||||||||||
The following table summarizes stock-based compensation grants: | ||||||||||||||||
Nine Months Ended | ||||||||||||||||
2-Nov-13 | 27-Oct-12 | |||||||||||||||
(In Thousands) | ||||||||||||||||
Stock options granted | 549 | 1,387 | ||||||||||||||
Restricted shares granted, excluding shares earned in lieu of cash dividends | 873 | 1,001 | ||||||||||||||
Total stock-based compensation grants | 1,422 | 2,388 | ||||||||||||||
Weighted average fair value at grant date: | ||||||||||||||||
Stock options | $ | 10.57 | $ | 11.84 | ||||||||||||
Restricted shares | $ | 47.97 | $ | 49 | ||||||||||||
Net_Income_Per_Section_Net_Inc
Net Income Per Section Net Income Per Section (Tables) | 9 Months Ended | |||||||||||||||
Nov. 02, 2013 | ||||||||||||||||
Net Income Per Section [Abstract] | ' | |||||||||||||||
Basic and diluted net income per share calculation | ' | |||||||||||||||
The following table summarizes our basic and diluted net income per share calculations: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
November 2, | October 27, | November 2, | October 27, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
(In Millions) | ||||||||||||||||
Numerator—Net income | $ | 177 | $ | 215 | $ | 555 | $ | 609 | ||||||||
Denominator—Weighted average shares: | ||||||||||||||||
Basic | 216 | 233 | 219 | 238 | ||||||||||||
Impact of dilutive employee stock options | 2 | 2 | 2 | 2 | ||||||||||||
Diluted | 218 | 235 | 221 | 240 | ||||||||||||
Antidilutive shares | 8 | 9 | 12 | 13 | ||||||||||||
Basis_of_Presentation_Narrativ
Basis of Presentation (Narrative) (Details) (USD $) | 3 Months Ended |
In Millions, unless otherwise specified | Oct. 27, 2012 |
Basis of Presentation (Narrative) [Abstract] | ' |
Accrued Liabilities, Current | $33 |
Debt_Components_of_Long_Term_D
Debt - Components of Long Term Debt (Details) (USD $) | Nov. 02, 2013 | Feb. 02, 2013 | Oct. 27, 2012 |
In Millions, unless otherwise specified | |||
Debt Instrument [Line Items] | ' | ' | ' |
Unamortized debt discount | ($8) | ($8) | ($8) |
Long-term debt | 2,792 | 2,492 | 2,492 |
Senior Notes | ' | ' | ' |
Debt Instrument [Line Items] | ' | ' | ' |
Effective Rate | 5.54% | 5.63% | 5.63% |
Total senior debt | 2,800 | 2,500 | 2,500 |
Senior Notes | Senior Notes Due 2017 | ' | ' | ' |
Debt Instrument [Line Items] | ' | ' | ' |
Effective Rate | 6.31% | 6.31% | 6.31% |
Debt Instrument, Interest Rate, Stated Percentage | 6.25% | 6.25% | 6.25% |
Total senior debt | 650 | 650 | 650 |
Senior Notes | Senior Notes Due 2021 | ' | ' | ' |
Debt Instrument [Line Items] | ' | ' | ' |
Effective Rate | 4.81% | 4.81% | 4.81% |
Debt Instrument, Interest Rate, Stated Percentage | 4.00% | 4.00% | 4.00% |
Total senior debt | 650 | 650 | 650 |
Senior Notes | Senior Notes Due 2023 | ' | ' | ' |
Debt Instrument [Line Items] | ' | ' | ' |
Effective Rate | 3.25% | 3.25% | 3.25% |
Debt Instrument, Interest Rate, Stated Percentage | 3.25% | 3.25% | 3.25% |
Total senior debt | 350 | 350 | 350 |
Senior Notes | Four Point Seven Eight Percent Senior Note Due Twenty Twenty Three [Member] [Domain] | ' | ' | ' |
Debt Instrument [Line Items] | ' | ' | ' |
Effective Rate | 4.78% | ' | ' |
Debt Instrument, Interest Rate, Stated Percentage | 4.75% | ' | ' |
Total senior debt | 300 | ' | 0 |
Senior Notes | Senior Notes Due 2029 | ' | ' | ' |
Debt Instrument [Line Items] | ' | ' | ' |
Effective Rate | 7.36% | 7.36% | 7.36% |
Debt Instrument, Interest Rate, Stated Percentage | 7.25% | 7.25% | 7.25% |
Total senior debt | 200 | 200 | 200 |
Senior Notes | Senior Notes Due 2033 | ' | ' | ' |
Debt Instrument [Line Items] | ' | ' | ' |
Effective Rate | 6.05% | 6.05% | 6.05% |
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | 6.00% | 6.00% |
Total senior debt | 300 | 300 | 300 |
Senior Notes | Senior Notes Due 2037 | ' | ' | ' |
Debt Instrument [Line Items] | ' | ' | ' |
Effective Rate | 6.89% | 6.89% | 6.89% |
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | 6.00% | 6.00% |
Total senior debt | $350 | $350 | $350 |
Fair_Value_Measurements_Narrat
Fair Value Measurements (Narrative) (Details) (USD $) | Nov. 02, 2013 | Feb. 02, 2013 | Oct. 27, 2012 | Jan. 28, 2012 | Nov. 02, 2013 | Feb. 02, 2013 | Oct. 27, 2012 | Nov. 02, 2013 | Nov. 02, 2013 | Nov. 02, 2013 |
In Millions, unless otherwise specified | Fair Value, Inputs, Level 1 | Fair Value, Inputs, Level 1 | Fair Value, Inputs, Level 1 | Fair Value, Inputs, Level 3 | Fair Value, Inputs, Level 3 | Fair Value, Inputs, Level 3 | ||||
Minimum | Maximum | |||||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash and Cash Equivalents, at Carrying Value | $598 | $537 | $550 | $1,205 | ' | ' | ' | ' | ' | ' |
Long-term investments, par value | 82 | 84 | 124 | ' | ' | ' | ' | ' | ' | ' |
Long Term Investments Fair Value | 57 | 53 | 90 | ' | ' | ' | ' | ' | ' | ' |
Long-term Debt, Excluding Current Maturities | 2,792 | 2,492 | 2,492 | ' | ' | ' | ' | ' | ' | ' |
Long term debt, fair value | ' | ' | ' | ' | $2,960 | $2,702 | $2,894 | ' | ' | ' |
Fair value inputs redemption period | ' | ' | ' | ' | ' | ' | ' | '7 years | ' | ' |
Investment maturity date range start | ' | ' | ' | ' | ' | ' | ' | '2037 | ' | ' |
Investment maturity date range end | ' | ' | ' | ' | ' | ' | ' | '2039 | ' | ' |
Discount rate | ' | ' | ' | ' | ' | ' | ' | ' | 6.57% | 9.47% |
Weighted Average Discount Rate, Percent | ' | ' | ' | ' | ' | ' | ' | 7.64% | ' | ' |
Fair_Value_Measurements_LongTe
Fair Value Measurements - Long-Term Investments (Details) (USD $) | 9 Months Ended | |
In Millions, unless otherwise specified | Nov. 02, 2013 | Oct. 27, 2012 |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ' | ' |
Balance at beginning of year | $53 | $153 |
Sales | -2 | -68 |
Unrealized gains | 6 | 5 |
Balance at end of quarter | $57 | $90 |
StockBased_Compensation_Summar
Stock-Based Compensation - Summary of Stock Based Compensation Grants (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, except Share data in Thousands, unless otherwise specified | Nov. 02, 2013 | Oct. 27, 2012 | Nov. 02, 2013 | Oct. 27, 2012 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Allocated Share-based Compensation Expense | $14 | $13 | $41 | $37 |
Stock options granted | ' | ' | 549 | 1,387 |
Restricted shares granted, excluding shares earned in lieu of cash dividends | ' | ' | 873 | 1,001 |
Total stock-based compensation grants | 1,422 | 2,388 | 1,422 | 2,388 |
Stock options | ' | ' | $10.57 | $11.84 |
Restricted shares | ' | ' | $47.97 | $49 |
Stock Options [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Allocated Share-based Compensation Expense | 4 | 5 | 13 | 22 |
Restricted Stock [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Allocated Share-based Compensation Expense | $10 | $8 | $28 | $15 |
Net_Income_Per_Section_Net_Inc1
Net Income Per Section Net Income Per Section (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, unless otherwise specified | Nov. 02, 2013 | Oct. 27, 2012 | Nov. 02, 2013 | Oct. 27, 2012 |
Net Income Per Section [Abstract] | ' | ' | ' | ' |
Net income | $177 | $215 | $555 | $609 |
Basic | 216 | 233 | 219 | 238 |
Impact of dilutive employee stock options | 2 | 2 | 2 | 2 |
Diluted | 218 | 235 | 221 | 240 |
Antidilutive shares | 8 | 9 | 12 | 13 |